1. Home
  2. RELI vs IXHL Comparison

RELI vs IXHL Comparison

Compare RELI & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RELI
  • IXHL
  • Stock Information
  • Founded
  • RELI 2013
  • IXHL 2001
  • Country
  • RELI United States
  • IXHL Australia
  • Employees
  • RELI N/A
  • IXHL N/A
  • Industry
  • RELI Specialty Insurers
  • IXHL
  • Sector
  • RELI Finance
  • IXHL
  • Exchange
  • RELI Nasdaq
  • IXHL Nasdaq
  • Market Cap
  • RELI 3.5M
  • IXHL 3.6M
  • IPO Year
  • RELI N/A
  • IXHL N/A
  • Fundamental
  • Price
  • RELI $1.47
  • IXHL $0.18
  • Analyst Decision
  • RELI
  • IXHL
  • Analyst Count
  • RELI 0
  • IXHL 0
  • Target Price
  • RELI N/A
  • IXHL N/A
  • AVG Volume (30 Days)
  • RELI 41.1K
  • IXHL 146.9M
  • Earning Date
  • RELI 07-24-2025
  • IXHL 05-15-2025
  • Dividend Yield
  • RELI N/A
  • IXHL N/A
  • EPS Growth
  • RELI N/A
  • IXHL N/A
  • EPS
  • RELI N/A
  • IXHL N/A
  • Revenue
  • RELI $14,208,143.00
  • IXHL $98,000.00
  • Revenue This Year
  • RELI N/A
  • IXHL $3,817.06
  • Revenue Next Year
  • RELI N/A
  • IXHL $66.67
  • P/E Ratio
  • RELI N/A
  • IXHL N/A
  • Revenue Growth
  • RELI 2.40
  • IXHL N/A
  • 52 Week Low
  • RELI $0.97
  • IXHL $0.08
  • 52 Week High
  • RELI $18.53
  • IXHL $3.55
  • Technical
  • Relative Strength Index (RSI)
  • RELI 68.56
  • IXHL 42.72
  • Support Level
  • RELI $1.29
  • IXHL $0.18
  • Resistance Level
  • RELI $1.56
  • IXHL $0.21
  • Average True Range (ATR)
  • RELI 0.09
  • IXHL 0.03
  • MACD
  • RELI 0.03
  • IXHL 0.01
  • Stochastic Oscillator
  • RELI 80.00
  • IXHL 6.64

About RELI Reliance Global Group Inc.

Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing acquisition strategies, initially and focused on wholesale and retail insurance agencies. Its primary strategies is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: